Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 30, Issue 4, Pages 337-343
Publisher
Springer Nature
Online
2012-03-19
DOI
10.1038/nbt.2157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Camouflage and sabotage: tumor escape from the immune system
- (2011) Isabel Poschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A viral strategy to ambush tumors
- (2011) Christopher Alvarez-Breckenridge et al. NATURE MEDICINE
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
- (2011) Timothy Kottke et al. NATURE MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating cancer with genetically engineered T cells
- (2011) Tristen S. Park et al. TRENDS IN BIOTECHNOLOGY
- Tumor vaccines in 2010: Need for integration
- (2010) David Koos et al. CELLULAR IMMUNOLOGY
- GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1
- (2010) M. P. Rausch et al. JOURNAL OF IMMUNOLOGY
- Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge
- (2010) J. A. Schwartz et al. JOURNAL OF VIROLOGY
- A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose
- (2010) M. A. Cobleigh et al. JOURNAL OF VIROLOGY
- Protection against Lethal Vaccinia Virus Challenge by Using an Attenuated Matrix Protein Mutant Vesicular Stomatitis Virus Vaccine Vector Expressing Poxvirus Antigens
- (2010) C. L. Braxton et al. JOURNAL OF VIROLOGY
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling
- (2010) Phonphimon Wongthida et al. MOLECULAR THERAPY
- Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide
- (2010) Candice Willmon et al. MOLECULAR THERAPY
- Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas
- (2009) T. Kottke et al. CANCER RESEARCH
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
- (2009) F Galivo et al. GENE THERAPY
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started